Asenapine

FDA Approved: * December 10, 2020
Pharm Company: * NEXGEN PHARMA INC
Category: Antipsychotic

Asenapine, sold under the brand name Saphris among others, is an atypical antipsychotic medication used to treat schizophrenia and acute mania associated with bipolar disorder.[2] It was chemically derived via altering the chemical structure of the tetracyclic (atypical) antidepressant, mianserin.[6] It was approved as a generic medication in the United States in 2020.[7] Contents 1 Medical uses 1.1 Schizophrenia 1.2 Acute mania 2 Adverse e... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Asenapine 5 mg Sublingual Tablet
NDC: 42794-016
Labeler:
Sigmapharm Laboratories, LLC
Asenapine 10 mg Sublingual Tablet
NDC: 42794-017
Labeler:
Sigmapharm Laboratories, LLC
Asenapine 5 mg Sublingual Tablet
NDC: 46708-198
Labeler:
Alembic Pharmaceuticals Limited
Asenapine 10 mg Sublingual Tablet
NDC: 46708-199
Labeler:
Alembic Pharmaceuticals Limited
Asenapine 2.5 mg Sublingual Tablet
NDC: 46708-544
Labeler:
Alembic Pharmaceuticals Limited
Asenapine 5 mg Sublingual Tablet
NDC: 51991-358
Labeler:
Breckenridge Pharmaceutical, Inc.
Asenapine 5 mg Sublingual Tablet
NDC: 51991-359
Labeler:
Breckenridge Pharmaceutical, Inc.
Asenapine 10 mg Sublingual Tablet
NDC: 51991-360
Labeler:
Breckenridge Pharmaceutical, Inc.
Asenapine 10 mg Sublingual Tablet
NDC: 51991-361
Labeler:
Breckenridge Pharmaceutical, Inc.
Asenapine 2.5 mg Sublingual Tablet
NDC: 51991-928
Labeler:
Breckenridge Pharmaceutical, Inc.
More Results

Related Brands

Drugs with the same active ingredients